---
$id: https://graph.org.ai/products/commodity/51131817
$type: Product
source: UNSPSC
code: "51131817"
title: "Eltrombopag"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eltrombopag

**UNSPSC Code**: 51131817
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an agent affecting blood and body fluid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S56D65XJ9G. European Medicines Agency schedules Eltrombopag in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30140. Eltrombopag generally arises in the molecular formula C25H22N4O4. The term ELTROMBOPAG is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56.) Most nations schedule eltrombopag under HS 29331900 and SITC 51571. As of Q4 2014, ELTROMBOPAG remains the US FDA Preferred Term for this commodity. Eltrombopag bears US NLM identifiers UMLS ID C1831905 and NCI Concept Code C71634. SMILES: O=C1N([NH]C(C1N/N=C1/C(=O)C(=CC=C1)C1CC(CCC1)C(=O)O)C)C1CC(C(CC1)C)C.

